本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

223.21
-3.7900-1.67%
盘后:223.210.00000.00%19:30 EDT
成交量:59.22万
成交额:1.33亿
市值:147.74亿
市盈率:17.58
高:228.91
开:225.99
低:222.21
收:227.00
52周最高:282.15
52周最低:186.05
股本:6,618.99万
流通股本:6,553.95万
量比:0.69
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):12.70
每股收益(LYR):-4.4176
净资产收益率:118.78%
总资产收益率:9.58%
市净率:9.18
市盈率(LYR):-50.53

数据加载中...

2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]